Antibodies under a microscope

DHJ24005

Research Grade Lodelcizumab

Description

LGT209, NVP-LGT209, CAS: 1355338-54-3

Targets

Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression